Cargando…

Background parenchymal enhancement in contrast-enhanced MR imaging suggests systemic effects of intrauterine contraceptive devices

OBJECTIVES: Levonorgestrel-releasing intrauterine contraceptive devices (LNG-IUDs) are designed to exhibit only local hormonal effects. There is an ongoing debate on whether LNG-IUDs can have side effects similar to systemic hormonal medication. Benign background parenchymal enhancement (BPE) in dyn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huck, Luisa Charlotte, Truhn, Daniel, Wilpert, Caroline, Zanderigo, Eloisa, Raaff, Vanessa, Dethlefsen, Ebba, Bode, Maike, Kuhl, Christiane Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Breast
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668774/ https://www.ncbi.nlm.nih.gov/pubmed/35524784 http://dx.doi.org/10.1007/s00330-022-08809-0

Ejemplares similares

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Feasibility study of 2D Dixon-Magnetic Resonance Fingerprinting (MRF) of breast cancer
por: Zanderigo, Eloisa, et al.
Publicado: (2022)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients
por: van der Velden, Bas H. M., et al.
Publicado: (2018)

Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
por: Ragusi, Max A. A., et al.
Publicado: (2020)

Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?
por: Wessling, Daniel, et al.
Publicado: (2022)

Evaluation of breast parenchymal density with QUANTRA software
por: Pahwa, Shivani, et al.
Publicado: (2015)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

The Impact of Progestin-only Contraception on Adolescents with Macromastia
por: Nuzzi, Laura C., et al.
Publicado: (2021)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology—preliminary results
por: Rudnicki, Wojciech, et al.
Publicado: (2019)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions
por: Veltman, J., et al.
Publicado: (2008)

Contrast-enhanced mammography-guided biopsy: technical feasibility and first outcomes
por: Alcantara, R., et al.
Publicado: (2022)

Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study
por: Cozzi, Andrea, et al.
Publicado: (2022)

Lymphatic Mapping with Contrast-enhanced Ultrasound for Lymphaticovenous Anastomosis Surgery: How We Do It
por: Jang, Samuel, et al.
Publicado: (2023)

Architecture distortion score (ADS) in malignancy risk stratification of architecture distortion on contrast-enhanced digital mammography
por: Goh, Yonggeng, et al.
Publicado: (2020)

Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours
por: Dominique, Caroline, et al.
Publicado: (2022)

Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
por: Lobbes, M. B. I., et al.
Publicado: (2019)

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2018)

Diffusion-weighted imaging in relation to morphology on dynamic contrast enhancement MRI: the diagnostic value of characterizing non-puerperal mastitis
por: Zhang, Lina, et al.
Publicado: (2017)

Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer
por: Hao, Yunxia, et al.
Publicado: (2021)

Automated artifact detection in abbreviated dynamic contrast-enhanced (DCE) MRI-derived maximum intensity projections (MIPs) of the breast
por: Kapsner, Lorenz A., et al.
Publicado: (2022)

Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2020)

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
por: Fangberget, A., et al.
Publicado: (2010)

Decreasing Time Intervals in Recurring Capsular Contracture? A Single Center Retrospective Study over 6 Years
por: Jakob, Vivian L., et al.
Publicado: (2023)

Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study
por: Lalji, U. C., et al.
Publicado: (2016)

Impact of contrast-enhanced mammography in surgical management of breast cancers for women with dense breasts: a dual-center, multi-disciplinary study in Asia
por: Goh, Yonggeng, et al.
Publicado: (2022)

Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria
por: Lalji, U. C., et al.
Publicado: (2015)

The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams
por: Milos, Ruxandra Iulia, et al.
Publicado: (2020)

An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
por: Pötsch, Nina, et al.
Publicado: (2021)

Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
por: Moliere, Sebastien, et al.
Publicado: (2019)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
por: Hu, Xiaoxin, et al.
Publicado: (2021)

Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement
por: Newell, Dustin, et al.
Publicado: (2009)

Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
por: Mann, Ritse M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tlcvkm54qkrh9tlbnnddpfaa06